At Australia’s PharmAus19 conference held at Parliament House in Canberra yesterday (October 15) new research was released, indicating that Australian’s were living longer, healthier lives thanks to the introduction of new medicines. The research, Measuring the Impact of Pharmaceutical Innovation in Australia 1998–2018, was conducted by Professor Frank Lichtenberg from Columbia University Business School and…

Read More

There was some promising news for the Australian multiple myeloma community this month with the Therapeutic Goods Administration (TGA) approval of a new triplet therapy. Myeloma is a life-threatening blood cancer, not to be confused with the skin cancer, melanoma. It develops from plasma cells typically found in the bone marrow and can affect multiple…

Read More

Pneumococcal pneumonia results in more than 77,000 hospitalisations and 4,000 deaths8 in Australia each year. Many of us carry pneumonia-causing bacteria in the back of our throats, which can take hold when the immune system becomes compromised or due to a viral infection such as the flu. Australians aged over 65 years are at significantly…

Read More

Given melanoma is our nation’s leading cancer affecting women (aged 20-to-24) and men (aged 35-to-50),1 the Australasian College of Dermatologists is today calling for early detection of skin cancer to save young Australian lives. The College’s plea is coinciding with an article just published in MJA Insight, in which the two co-authors, leading Queensland-based skin…

Read More

One-in-two Australians will be diagnosed with cancer by the age of 85, and an estimated 145,000 new cancer diagnoses are expected in 2019. It is our nation’s leading cause of death, and while survival rates continue to improve with advances in treatment, there is still much to be learned about how individual responses to treatment. When patients…

Read More